These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26762730)

  • 21. Canadian Registry of Implantable Electronic Device Outcomes: Longer-term follow-up of the Riata lead under advisory.
    Parkash R; Thibault B; Philippon F; Mangat I; Coutu B; Bennett M; Crystal E; Healey J; Verma A; Sandhu R; Cameron D; Ayala-Paredes F; Sterns L; Essebag V; Sturmer M; Nery P; Wells G; Krahn A
    Heart Rhythm; 2018 Apr; 15(4):524-529. PubMed ID: 29198903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis.
    Pokorney SD; Zhou K; Matchar DB; Love S; Zeitler EP; Lewis R; Piccini JP
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):184-91. PubMed ID: 25311559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure-free survival of the Durata defibrillator lead.
    Liu J; Patel D; Rattan R; Brumberg G; Saini A; Vaghasia N; Bazaz R; Adelstein E; Jain S; Saba S
    Europace; 2013 Jul; 15(7):1002-6. PubMed ID: 23376976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of insulation failure with externalized cables in St. Jude Medical Riata family ICD leads: fluoroscopic grading scale and correlation to extracted leads.
    Parvathaneni SV; Ellis CR; Rottman JN
    Heart Rhythm; 2012 Aug; 9(8):1218-24. PubMed ID: 22449742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
    J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of asymptomatic and electrically undetectable intracardiac inside-out abrasion in silicon-coated Riata® and Riata® ST implantable cardioverter-defibrillator leads.
    Schmutz M; Delacrétaz E; Schwick N; Roten L; Fuhrer J; Boesch C; Tanner H
    Int J Cardiol; 2013 Jul; 167(1):254-7. PubMed ID: 22236515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Sprint Fidelis and Riata defibrillator lead failure rates.
    Fazal IA; Shepherd EJ; Tynan M; Plummer CJ; McComb JM
    Int J Cardiol; 2013 Sep; 168(2):848-52. PubMed ID: 23138013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conductor externalization of the Riata internal cardioverter defibrillator lead: tip of the iceberg? Report of three cases and review of literature.
    Dorman HG; van Opstal JM; Stevenhagen J; Scholten MF
    Europace; 2012 Aug; 14(8):1161-4. PubMed ID: 22431444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective nationwide fluoroscopic and electrical longitudinal follow-up of recalled Riata defibrillator leads in Denmark.
    Larsen JM; Nielsen JC; Johansen JB; Haarbo J; Petersen HH; Thøgersen AM; Hjortshøj SP
    Heart Rhythm; 2014 Dec; 11(12):2141-7. PubMed ID: 25008285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and presentation of externalized conductors and electrical abnormalities in Riata defibrillator leads after fluoroscopic screening: report from the Netherlands Heart Rhythm Association Device Advisory Committee.
    Theuns DA; Elvan A; de Voogt W; de Cock CC; van Erven L; Meine M
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1059-63. PubMed ID: 23091049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
    Ellis CR; Rottman JN
    Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term performance and lead failure analysis of the Durata defibrillation lead compared to its previous model, the recalled Riata defibrillation lead.
    Kleemann T; Nonnenmacher F; Strauss M; Kouraki K; Werner N; Fendt A; Zahn R
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2012-2019. PubMed ID: 31332876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of lead failure manifestation of Biotronik Linox with St. Jude Medical Riata and Medtronic Sprint Fidelis lead.
    Lam A; Buehler S; Goulouti E; Sweda R; Haeberlin A; Medeiros-Domingo A; Servatius H; Seiler J; Baldinger S; Noti F; Tanner H; Roten L
    J Interv Card Electrophysiol; 2019 Mar; 54(2):161-170. PubMed ID: 30471050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect.
    Hauser RG; McGriff D; Retel LK
    Heart Rhythm; 2012 May; 9(5):742-9. PubMed ID: 22209723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insight into the mechanism of failure of the Riata lead under advisory.
    Parkash R; Tung S; Champagne J; Healey JS; Thibault B; Cameron D; Tang A; Connors S; Beardsall M; Mangat I; Ayala-Paredes F; Toal S; Exner D; Yee R; Krahn AD
    Heart Rhythm; 2015 Mar; 12(3):574-579. PubMed ID: 25485777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads.
    Ellenbogen KA; Gunderson BD; Stromberg KD; Swerdlow CD
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1169-77. PubMed ID: 24099976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator.
    Danik SB; Mansour M; Singh J; Reddy VY; Ellinor PT; Milan D; Heist EK; d'Avila A; Ruskin JN; Mela T
    Heart Rhythm; 2007 Apr; 4(4):439-42. PubMed ID: 17399630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of the St. Jude Medical Riata leads.
    Epstein AE; Baker JH; Beau SL; Deering TF; Greenberg SM; Goldman DS
    Heart Rhythm; 2009 Feb; 6(2):204-9. PubMed ID: 19103512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of the Riata Lead Under Advisory.
    Parkash R; Thibault B; Mangat I; Coutu B; Bennett M; Healey J; Verma A; Philippon F; Sandhu R; Cameron D; Ayala-Paredes F; Sterns L; Essebag V; Kus T; Nery P; Stephenson E; Yee R; Exner D; Toal S; Birnie D; Wells G; Krahn A
    Circ Arrhythm Electrophysiol; 2016 Oct; 9(10):. PubMed ID: 27733493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.